- Home
- CCTG vs SPRB Comparison
CCTG vs SPRB Comparison
Compare CCTG & SPRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCTG
- SPRB
- Stock Information
- Founded
- CCTG 1993
- SPRB 2014
- Country
- CCTG Hong Kong
- SPRB United States
- Employees
- CCTG N/A
- SPRB N/A
- Industry
- CCTG
- SPRB Medicinal Chemicals and Botanical Products
- Sector
- CCTG
- SPRB Health Care
- Exchange
- CCTG Nasdaq
- SPRB Nasdaq
- Market Cap
- CCTG 18.1M
- SPRB 15.7M
- IPO Year
- CCTG 2024
- SPRB 2020
- Fundamental
- Price
- CCTG $1.73
- SPRB $0.36
- Analyst Decision
- CCTG
- SPRB Hold
- Analyst Count
- CCTG 0
- SPRB 7
- Target Price
- CCTG N/A
- SPRB $2.17
- AVG Volume (30 Days)
- CCTG 368.7K
- SPRB 595.7K
- Earning Date
- CCTG 12-27-2024
- SPRB 03-12-2025
- Dividend Yield
- CCTG N/A
- SPRB N/A
- EPS Growth
- CCTG N/A
- SPRB N/A
- EPS
- CCTG N/A
- SPRB N/A
- Revenue
- CCTG $16,463,490.00
- SPRB $7,101,000.00
- Revenue This Year
- CCTG N/A
- SPRB N/A
- Revenue Next Year
- CCTG N/A
- SPRB N/A
- P/E Ratio
- CCTG N/A
- SPRB N/A
- Revenue Growth
- CCTG 3.27
- SPRB N/A
- 52 Week Low
- CCTG $1.20
- SPRB $0.34
- 52 Week High
- CCTG $30.00
- SPRB $5.95
- Technical
- Relative Strength Index (RSI)
- CCTG 50.65
- SPRB 37.97
- Support Level
- CCTG $1.60
- SPRB $0.34
- Resistance Level
- CCTG $1.93
- SPRB $0.39
- Average True Range (ATR)
- CCTG 0.23
- SPRB 0.03
- MACD
- CCTG 0.00
- SPRB 0.00
- Stochastic Oscillator
- CCTG 31.88
- SPRB 20.73
About CCTG CCSC Technology International Holdings Limited
CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas and Asia.
About SPRB Spruce Biosciences Inc.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).